Skip to content Skip to main navigation Report an accessibility issue

21st Century Cures: Southeast Conference

March 27, 2019

21st Century Cures: Southeast Conference
Howard H. Baker Jr. Center for Public Policy

8 a.m.–6:30 p.m.

2019 Program Book

Hotel and Parking Logistics

The University of Tennessee, Knoxville (UT), will host its third 21st Century Cures: Southeast Conference in March 2019 which will focus on applying systems biology to biomedical research.

Guests will hear insights from prestigious scientists, learn about research priorities and funding opportunities from leaders at the National Institutes of Health, and meet potential collaborators from across the Southeast. In addition, the event will include an interactive poster session to allow faculty and students to share their ideas with other attendees. Abstracts are currently being accepted for poster display.

Photos from the 2017 21st Century Cures: Southeast Conference
Photos from the 2018 21st Century Cures: Southeast Conference

This year’s conference continues the momentum and enthusiasm from the inaugural event, held in 2017, which focused on the intersection of the Act’s national research priorities with regional strengths in computational approaches, data analytics, basic biology, and materials science. Researchers from fifteen institutions across the Southeast gathered to learn about regional health challenges and form partnerships to address them.

Available Tracks and Speakers for 2019

Keynote Speakers:

Opening Keynote: Grace C.Y. Peng, Director of Computational Modeling, Simulation, and Analysis at the National Institute of Biomedical Imaging and Bioengineering

Track 1: Computational Modeling of Health

This track will focus scientific inquiry related to questions such as: How can computational modeling impact human health through studying the behavior of complex, multi-level biological systems at the cellular and subcellular level? How can computational modeling improve our understanding of diseases and how to characterize, predict, and treat them? How can advances in multiscale modeling reveal new patterns or combinations that can be used to optimize decisions and improve outcomes? How can big data be transformed into computational models for precision medicine, drug design and delivery, and treatments for diseases like influenza, cancer, and Alzheimer’s disease?

Speakers:

Belinda Akpa, Assistant Professor of Integrated Synthetic and Systems Biology at North Carolina State University

Liliana Brown, Program Officer in the Office of Genomics and Advanced Technologies (OGAT) at the National Institute for Allergy and Infectious Diseases

Tian Hong, Assistant Professor in the Department of Biochemistry, Cellular, and Molecular Biology at the University of Tennessee, Knoxville

Shannon Hughes, Program Director in the Division of Cancer Biology at the National Cancer Institute

Rachel Patton McCord, Assistant Professor in the Department of Biochemistry, Cellular, and Molecular Biology at the University of Tennessee, Knoxville

Veerasamy (Ravi) Ravichandran, Program Director in the Division of Biophysics, Biomedical Technology, and Computational Biology at the National Institute of General Medical Sciences

Eric Stahlberg, Director of Biomedical Informatics and Data Science at Frederick National Laboratory for Cancer Research

 

Track 2: Microbes and Health

Track 2 will focus scientific inquiry related to questions such as: What roles do microbes play in human health—whether it’s shaping our development, regulating our metabolic functions, providing disease markers, or contributing to our overall well-being? How can a systems biology approach shed new light on the ways microbes influence human health? How do changes or disruptions in the delicate human microbiome cause or contribute to some of our most perplexing ailments? How are new microbial discoveries being applied to unlock novel solutions to health challenges? How can a systems biology approach to the human microbiome be integrated into precision medicine and treatments for diseases like influenza, cancer, and Alzheimer’s disease?

Speakers:

Andrea Azcarate-Peril, Associate Professor of Medicine at the University of North Carolina School of Medicine

Mariana Xavier Byndloss, Assistant Professor of Pathology, Microbiology, and Immunology at Vanderbilt University Medical Center

Melissa Cregger, Staff Scientist in the Biosciences Division at Oak Ridge National Laboratory

Phil Daschner, Program Director in the Cancer Immunology, Hematology, and Etiology Branch at the National Cancer Institute

Joseph Pierre, Assistant Professor in the Department of Pediatrics at the University of Tennessee Health Science Center

Mircea Podar, Distinguished Staff Scientist and Leader of the Systems Genetics Group in the Biosciences Division at Oak Ridge National Laboratory

 

The 21st Century Cures Act, passed in 2016, allocates $4.8 billion to address some of the most pressing human health challenges of our time. The National Institutes of Health will use this infusion of funding to accelerate research on cancer, the brain, and precision medicine.

2017 Program Book

2018 Program Book

Please contact Jennifer Webster (jwebster@utk.edu), in the Office of Research and Engagement with any questions about the event.